Objective: The objective of this study was to assess vestibular functions in patients with chronic suppurative otitis media (CSOM) with and without sensorineural hearing loss. Study Design: This was a prospective case study performed at a tertiary referral university hospital. Sixty patients with CSOM were included, and patients with a history of head trauma, diabetes, hypertension, previous ear surgery, use of ototoxic drugs, neurological deficits and suspected fistulae were excluded. Patients and Methods: The patients underwent basic audiological evaluation, and clinical and instrumental vestibular evaluation. The incidence and extent of vestibular dysfunction in patients with CSOM were analyzed. Results: A total of 42 males and 16 females with a mean age of 29.5 years were included in this study. Forty ears had tubotympanic disease and 19 had cholesteatoma. There were 14 ears with sensorineural hearing loss. A positive history of vertigo was reported in 53.5% of the cases. Rotatory chair abnormalities were found in 70% of the cases, caloric hypofunction was found in 61.6%, and vestibular myogenic evoked potentials were abnormal in 25%. The only positive correlation with vestibular dysfunction was the duration of disease. Conclusions: The vestibular system is significantly affected in cases with CSOM. Both semicircular canals and the saccule are affected. All patients with long-standing CSOM should be evaluated for vestibular dysfunction irrespective of their hearing levels.

Keywords:
Chronic suppurative otitis media, Vertigo, Vestibular testing, Vestibular function, Videonystagmography, Rotatory chair
1.
Pajor A, Gryczynski M, Lukomski M, Jozefowicz-Korczynska M: Vestibular system in patients with sensorineural hearing loss. Otolaryngol Pol 2002;56:707-712.
2.
Papp Z, Rezes S, Jokay I, Sziklai I: Sensorineural hearing loss in chronic otitis media. Otol Neurotol 2003;24:141-144.
3.
Redaelli de Zinis LO, Campovecchi C, Parrinello G, Antonelli AR: Predisposing factors for inner ear hearing loss association with chronic otitis media. Int J Audiol 2005;44:593-598.
4.
Takumida M, Anniko M: Localization of endotoxin in the inner ear following inoculation into the middle ear. Acta Otolaryngol 2004;124:772-777.
5.
Juhn S, Tsuprun V, Lee Y-W, Hunter B, Schachern P: Interaction between middle and inner ear in otitis media. Audiolog Med 2004;3:158-161.
6.
Pal'chun VT, Kunel'skaia NL, Petlinov AP: The vestibular function in patients with various forms of chronic purulent otitis media. Vestn Otorinolaringol 2004;6:13-17.
7.
Pal'chun VT, Kunel'skaia NL, Mironov AA, Ganichkina Iia, Petlinov AP: Myringoplasty and its effects on a vestibular function in patients with otitis media purulenta chronica. Vestn Otorinolaringol 2005;2:19-21.
8.
Siampara L, Mann SBS, Panda NK, Mehra YN: Audiovestibular profile in unilateral chronic suppurative otitis media. Ind J Otolaryngol Head Neck Surg 1997;49:107-111.
9.
Gianoli GJ, Soileau JS: Preoperative vestibular testing in chronic suppurative otitis media. Otolaryngol Head Neck Surg 2005;2:75-76.
10.
Gianoli GJ, Soileau JS: Chronic suppurative otitis media, caloric testing, and rotational chair testing. Otol Neurotol 2007;29:13-15.
11.
Nordang L, Anniko M: Hearing loss in relation to the round window membrane morphology in experimental chronic otitis media. ORL J Otorhinolaryngol Relat Spec 2001;63:333-340.
12.
Lee I-S, Park HJ, Shin JE, Jeong YS, Kwak HB, Lee YJ: Results of air caloric and other vestibular tests in patients with chronic otitis media. Clinical Exper Otolaryngol 2009;3:145-150.
13.
Wang MC, Liu C-Y, Yu EC, Wu H-J, Lee G-S: Vestibular evoked myogenic potentials in chronic otitis media before and after surgery. Acta Otolaryngol 2009;129:1206-1211.
© 2014 S. Karger AG, Basel
2014
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.